Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Interest & Investment Income (2010 - 2026)

Updated

Capricor Therapeutics (CAPR) recorded Interest & Investment Income of $2.21 million in Q2 2026, up 23.3% from $1.79 million a year earlier but down 23.9% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Interest & Investment Income (2010 - 2026) Analysis & Trends

On a TTM basis, Capricor Therapeutics' Interest & Investment Income came in at $8.85 million as of Jun 30, 2026, up 141.6% year-over-year; for FY2025, it was $6.26 million, up 184.1% from FY2024.

  • Annual Interest & Investment Income has increased for five straight years, with a five-year compound annual growth rate of 185.6% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $2.2 million in FY2024 (+27.4%), $1.73 million in FY2023 (+231.5%), $521,535 in FY2022 (+807.6%) and $57,460 in FY2021 (+74.4%).
  • Quarterly Interest & Investment Income has ranged from $13,440 in Q1 2022 to $2.9 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Interest & Investment Income has increased for seven consecutive quarters, with growth averaging 137.3% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 584.9% in Q3 2022, against a decline of 5.5% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.9 million (Q1 2026), $2.02 million (Q4 2025) and $1.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Capricor Therapeutics 520.08 Mn 520.08 Mn - 2.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.21 Mn
Mar 31, 2026 2.90 Mn
Dec 31, 2025 2.02 Mn
Sep 30, 2025 1.71 Mn
Jun 30, 2025 1.79 Mn
Mar 31, 2025 729,542.00
Dec 31, 2024 686,572.00
Sep 30, 2024 453,152.00
Jun 30, 2024 591,437.00
Mar 31, 2024 471,829.00
Dec 31, 2023 452,199.00
Sep 30, 2023 479,380.00
Jun 30, 2023 380,680.00
Mar 31, 2023 416,442.00
Dec 31, 2022 379,699.00
Sep 30, 2022 106,635.00
Jun 30, 2022 21,761.00
Mar 31, 2022 13,440.00
Dec 31, 2021 15,984.00
Sep 30, 2021 15,570.00
API Access

Capricor Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CAPR&period=max&api_key=YOUR_API_KEY